Ginkgo Bioworks (DNA) appoints Steven Coen as CFO

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Mark Dmytruk, the Company's Chief Financial Officer, intends to resign from his role at the Company on May 30, 2025 to accept a position at another organization and Steven Coen, CPA, the Company's Chief Accounting Officer, will become Chief Financial Officer, effective upon Mr. Dmytruk's resignation.

Mr. Coen joined the Company on May 1, 2023 with over 30 years of public accounting and corporate finance leadership experience. Prior to his role at Ginkgo, Mr. Coen was the Corporate Vice President and Corporate Controller for Charles River Laboratories, a publicly held global contract research organization for pharmaceutical and biotechnology companies, governmental agencies and leading academic institutions, with approximately 20,000 employees across 150 locations in over 20 countries and annual revenues of approximately $4.0 billion. Prior to that, Mr. Coen served in accounting and finance leadership roles in the technology and medical device industries after spending more than 17 years in the audit practice at Deloitte & Touche LLP.

"We thank Mark for his dedicated service to the Company and his leadership of the finance team through many transformational phases at Ginkgo and wish him well in his next opportunity," said Jason Kelly, co-founder and CEO of Ginkgo Bioworks. "I'm excited to elevate Steve to his new role stewarding the finance and accounting functions and we're fortunate to have the continuity of building on his experience at Ginkgo the past two years."

"It has been a privilege to work alongside the leadership team and all the talented Bioworkers across Ginkgo," said Mr. Dmytruk. "I am deeply grateful for the opportunity to have contributed to Ginkgo's mission of making biology easier to engineer, and I have full confidence in Steve and the finance team to continue driving the Company's financial vision forward."

"Mark has built a high-performing finance organization and laid the groundwork for Ginkgo to continue driving toward our cost reduction targets and our goal of reaching Adjusted EBITDA breakeven by the end of 2026," said Mr. Coen. "I've greatly enjoyed working with Mark over the past two years and am ready to build upon the financial vision and strategy he has laid out."

Mr. Coen earned a B.S. in Accounting and an A.S. in Management from Bentley University and is a Certified Public Accountant in Massachusetts.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• Steakholder Foods adjusts ADS ratio in a 1-for-3 reverse split
• Digital Brands Group announces 1-for-40 reverse stock split